| 持有 复星医药(600196)的基金 |
| 报告期：2021-03-31 |
| 序号 |
基金代码 |
基金简称 |
持仓市值(元) |
持仓数量(股) |
占基金净值比例(%) |
| 1 | 161726 | 招商国证生物医药指数分级 | 562,143,809.14 | 14,127,766.00 | 4.42 |
| 2 | 159992 | 银华中证创新药产业ETF | 146,679,548.18 | 3,686,342.00 | 3.76 |
| 3 | 501010 | 汇添富中证生物科技指数(LOF)C | 69,202,807.79 | 1,739,201.00 | 3.34 |
| 4 | 501009 | 汇添富中证生物科技指数(LOF)A | 69,202,807.79 | 1,739,201.00 | 3.34 |
| 5 | 515120 | 广发中证创新药产业ETF | 46,056,129.20 | 1,157,480.00 | 3.59 |
| 6 | 010159 | 中银医疗保健混合C | 32,591,989.00 | 819,100.00 | 2.87 |
| 7 | 005689 | 中银医疗保健混合A | 32,591,989.00 | 819,100.00 | 2.87 |
| 8 | 005985 | 兴业聚华混合C | 18,223,820.00 | 458,000.00 | 1.67 |
| 9 | 005984 | 兴业聚华混合A | 18,223,820.00 | 458,000.00 | 1.67 |
| 10 | 002330 | 兴业聚宝灵活配置混合 | 18,060,681.00 | 453,900.00 | 4.17 |
| 11 | 001257 | 兴业收益增强债券A | 6,843,880.00 | 172,000.00 | 1.49 |
| 12 | 001258 | 兴业收益增强债券C | 6,843,880.00 | 172,000.00 | 1.49 |
| 13 | 510660 | 华夏医药ETF | 5,386,770.20 | 135,380.00 | 4.72 |
| 14 | 165519 | 信诚中证800医药指数分级 | 5,075,134.92 | 127,548.00 | 2.47 |
| 15 | 512120 | 华安中证细分医药ETF | 3,790,793.30 | 95,270.00 | 2.72 |
| 16 | 515960 | 嘉实医药健康100成长估值ETF | 2,092,954.00 | 52,600.00 | 2.64 |
| 17 | 008222 | 兴业机遇债券C | 1,074,330.00 | 27,000.00 | 1.73 |
| 18 | 005717 | 兴业机遇债券A | 1,074,330.00 | 27,000.00 | 1.73 |
| 19 | 008400 | 华泰柏瑞中证科技ETF联接C | 835,590.00 | 21,000.00 | 0.20 |
| 20 | 008399 | 华泰柏瑞中证科技ETF联接A | 835,590.00 | 21,000.00 | 0.20 |
| 21 | 004222 | 金信民旺债券A | 795,800.00 | 20,000.00 | 4.14 |
| 22 | 004402 | 金信民旺债券C | 795,800.00 | 20,000.00 | 4.14 |
